Free Trial

Pactiv Evergreen (PTVE) Stock Forecast & Price Target

Pactiv Evergreen logo
$11.34
-0.10 (-0.87%)
(As of 05:17 PM ET)

Pactiv Evergreen - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
2
Buy
5

Based on 7 Wall Street analysts who have issued ratings for Pactiv Evergreen in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 2 have given a hold rating, and 5 have given a buy rating for PTVE.

Consensus Price Target

$14.57
26.82% Upside
According to the 7 analysts' twelve-month price targets for Pactiv Evergreen, the average price target is $14.57. The highest price target for PTVE is $18.00, while the lowest price target for PTVE is $12.00. The average price target represents a forecasted upside of 26.82% from the current price of $11.34.
Get the Latest News and Ratings for PTVE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Pactiv Evergreen and its competitors.

Sign Up

PTVE Analyst Ratings Over Time

TypeCurrent Forecast
11/1/23 to 10/31/24
1 Month Ago
10/2/23 to 10/1/24
3 Months Ago
8/3/23 to 8/2/24
1 Year Ago
11/1/22 to 11/1/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$14.57$14.57$15.43$10.50
Forecasted Upside26.82% Upside26.16% Upside58.57% Upside23.09% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

PTVE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PTVE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Pactiv Evergreen Stock vs. The Competition

TypePactiv EvergreenConsumer Discretionary CompaniesS&P 500
Consensus Rating Score
2.71
2.58
2.50
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside26.16% Upside1,199.18% Upside10.09% Upside
News Sentiment Rating
Positive News

See Recent PTVE News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/8/2024UBS Group
4 of 5 stars
 Lower TargetBuy ➝ Buy$16.00 ➝ $15.00+43.95%
8/7/2024Royal Bank of Canada
4 of 5 stars
 Lower TargetOutperform ➝ Outperform$15.00 ➝ $13.00+27.08%
8/2/2024Robert W. Baird
2 of 5 stars
 Lower TargetNeutral ➝ Neutral$15.00 ➝ $12.00+23.33%
7/8/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$16.00 ➝ $14.00+24.56%
3/4/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$12.50 ➝ $14.00+5.58%
1/19/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$18.00+27.48%
1/2/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$14.00 ➝ $16.00+16.70%
5/10/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$14.00 ➝ $11.00+46.86%
3/8/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$13.00 ➝ $12.00+21.95%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:46 PM ET.


PTVE Forecast - Frequently Asked Questions

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Pactiv Evergreen is $14.57, with a high forecast of $18.00 and a low forecast of $12.00.

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pactiv Evergreen in the last twelve months. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PTVE shares.

According to analysts, Pactiv Evergreen's stock has a predicted upside of 28.50% based on their 12-month stock forecasts.

Pactiv Evergreen has been rated by research analysts at Robert W. Baird, Royal Bank of Canada, and UBS Group in the past 90 days.

Analysts like Pactiv Evergreen more than other "consumer discretionary" companies. The consensus rating score for Pactiv Evergreen is 2.71 while the average consensus rating score for "consumer discretionary" companies is 2.58. Learn more on how PTVE compares to other companies.


This page (NASDAQ:PTVE) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners